Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit [Yahoo! Finance]
Edesa Biotech, Inc. - Common Shares (EDSA)
Company Research
Source: Yahoo! Finance
TORONTO, March 31, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced that its chief executive officer, Dr. Par Nijhawan, has been selected to deliver the inaugural presentation at the Oral Showcase at the ATS 2026 Respiratory Innovation Summit (RIS), organized by the American Thoracic Society (ATS). Dr. Nijhawan's presentation will feature findings from Edesa's Phase 3 study of paridiprubart (EB05), Edesa's first-in-class anti-TLR4 antibody evaluated as a treatment for Acute Respiratory Distress Syndrome (ARDS), a life-threatening condition accounting for over three million ICU admissions globally each year. Edesa has recently reported two sets of Phase 3 results for paridiprubart. Initial data covered 104 patients requiring invasive mechanical ventilation (IMV). Expanded results encompass a broader 278-patient population — includin
Show less
Read more
Impact Snapshot
Event Time:
EDSA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EDSA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EDSA alerts
High impacting Edesa Biotech, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
EDSA
News
- Edesa Biotech (EDSA) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=EDSA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "sell" to "MarketBeat
- Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit [TheStreet.com]TheStreet.com
- Edesa Biotech Invited for Oral Showcase at Respiratory Innovation SummitGlobeNewswire
- Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 EnrollmentGlobeNewswire
- Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart StudyGlobeNewswire
EDSA
Sec Filings
- 4/3/26 - Form ARS
- 4/3/26 - Form DEFA14A
- 4/3/26 - Form DEF
- EDSA's page on the SEC website